Upgrade to SI Premium - Free Trial

Amgen (AMGN) PT Raised to $175 at Oppenheimer

February 3, 2017 6:21 AM
Oppenheimer raised its price target on Amgen (NASDAQ: AMGN) to $175.00 (from $166.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles